Click to Translate to English Click to Translate to French  Click to Translate to Spanish  Click to Translate to German  Click to Translate to Italian  Click to Translate to Japanese  Click to Translate to Chinese Simplified  Click to Translate to Korean  Click to Translate to Arabic  Click to Translate to Russian  Click to Translate to Portuguese

Forum Home Forum Home > General Discussion > General Discussion
  New Posts New Posts RSS Feed - Roche Gets Approval for First Zika Virus Screening
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Online Discussion: Tracking new emerging diseases and the next pandemic

Roche Gets Approval for First Zika Virus Screening

 Post Reply Post Reply
Technophobe View Drop Down
Senior Moderator
Senior Moderator

Joined: January 16 2014
Location: Scotland
Status: Offline
Points: 50855
Post Options Post Options   Thanks (0) Thanks(0)   Quote Technophobe Quote  Post ReplyReply Direct Link To This Post Topic: Roche Gets Approval for First Zika Virus Screening
    Posted: October 09 2017 at 2:38pm

Roche Gets Approval for First Zika Virus Screening Test

 By Kapitall

The FDA has approved a Zika detection test for blood donations created by Roche ( RHHBY ) as the government tries to stave off the relatively novel disease. 

"Screening blood donations for the Zika virus is critical to preventing infected donations from entering the U.S blood supply. Today's approval is the result of a commitment by the manufacturer to work rapidly and collaboratively with the FDA and the blood collection industry to respond to a public health crisis and enrue the safety of blood in the U.S and its territories" states Dr. Peter Marks, Director of the FDA Center for Biologics Evaluation and Research. 

Since the Zika virus can be transferred both by mosquitos and through sexual contact without any symptoms, a test for the disease is a necessity, Zika can cause neurological damage in adults and birth defects in unborn children.

Roche cinched the deal by testing blood in 5 different laboratory settings and had a certainty rate of 99%. The test is specifically designed for Roche's molecular diagnostic system, cobas . 

You can read the full report here . 

Original source:

Absence of proof is not proof of absence.
Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down